Immune-mediated necrotizing myopathy following vaccination with the AstraZeneca (AZD1222) COVID-19 vaccine: A case report and brief review.
Rev Neurol (Paris)
; 179(6): 630-635, 2023 Jun.
Article
in English
| MEDLINE | ID: covidwho-2221192
ABSTRACT
Immune-Mediated Necrotizing Myopathy (IMNM) after vaccination has been reported previously, however it is rare after COVID-19 vaccination. We report the first case of IMNM two weeks after vaccination with the AstraZeneca (AZD1222) COVID-19 vaccine. There was a probable temporal relationship between the COVID-19 vaccination and the development of IMNM due to lack of known causative factors for IMNM. This may have been due to 1) autoimmunity directly caused by the vaccine, 2) exacerbation of autoimmunity triggered by the vaccine or 3) autoimmune syndrome triggered by the vaccine adjutants. Further studies are needed to assess the underlying mechanisms.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
COVID-19 Vaccines
/
COVID-19
/
Muscular Diseases
Type of study:
Case report
/
Observational study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Rev Neurol (Paris)
Year:
2023
Document Type:
Article
Affiliation country:
J.neurol.2022.11.009
Similar
MEDLINE
...
LILACS
LIS